| Literature DB >> 26183924 |
Monica Bodogai1, Kanako Moritoh1, Catalina Lee-Chang1, Christine M Hollander2, Cheryl A Sherman-Baust1, Robert P Wersto3, Yoshihiko Araki4, Ichiro Miyoshi5, Li Yang2, Giorgio Trinchieri6, Arya Biragyn7.
Abstract
Myeloid-derived suppressive cells (MDSC) have been reported to promote metastasis, but the loss of cancer-induced B cells/B regulatory cells (tBreg) can block metastasis despite MDSC expansion in cancer. Here, using multiple murine tumor models and human MDSC, we show that MDSC populations that expand in cancer have only partially primed regulatory function and limited prometastatic activity unless they are fully educated by tBregs. Cancer-induced tBregs directly activate the regulatory function of both the monocyte and granulocyte subpopulations of MDSC, relying, in part, on TgfβR1/TgfβR2 signaling. MDSC fully educated in this manner exhibit an increased production of reactive oxygen species and NO and more efficiently suppress CD4(+) and CD8(+) T cells, thereby promoting tumor growth and metastasis. Thus, loss of tBregs or TgfβR deficiency in MDSC is sufficient to disable their suppressive function and to block metastasis. Overall, our data indicate that cancer-induced B cells/B regulatory cells are important regulators of the immunosuppressive and prometastatic functions of MDSC. ©2015 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26183924 PMCID: PMC4558269 DOI: 10.1158/0008-5472.CAN-14-3077
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701